LATEST MANUSCRIPTS IN Therapeutics and Clinical Risk Management
Jennifer Gallardo-Cóndor, Pablo Naranjo, Sebastián Atarihuana, Dayana Coello, Patricia Guevara-Ramírez, Rodrigo Flores-Espinoza, Germán Burgos, Andrés López-Cortés, Alejandro Cabrera-Andrade. Population-Specific Distribution of Deficiency Variants and Ancestry Proportions in Ecuadorian Ethnic Groups: Towards Personalized Medicine.Therapeutics and clinical risk management. 2023, 19: 1005-1018
Samuel Frank, Aljoharah Alakkas. Clinical Utility of Deutetrabenazine as a Treatment Option for Chorea Associated with Huntington's Disease and Tardive Dyskinesia.Therapeutics and clinical risk management. 2023, 19: 1019-1024
Chutipong Kwantong, Yuda Sutherasan, Detajin Junhasavasdikul, Tananchai Petnak, Pongdhep Theerawit. Effect of the Ramathibodi Rapid Response System Triggered by the Ramathibodi Early Warning Score and Clinical Warning Signs on in-Hospital Mortality and the Incidence of Cardiopulmonary Resuscitation in Adult Hospitalized Patients.Therapeutics and clinical risk management. 2023, 19: 1025-1038
Han Qi, Zhitao Zhu, Dongsheng Zhu. Erythrocyte Sedimentation Rate for Assisted Diagnosis of Pediatric Osteomyelitis: A Meta-Analysis.Therapeutics and clinical risk management. 2023, 19: 1039-1049
María A Rodríguez-Scarpetta, Andrés M Sepúlveda-Tobón, Jorge E Daza-Arana, Heiler Lozada-Ramos, Rodrigo A Álzate-Sánchez. Central Oxygen Venous Saturation and Mortality in Patients Undergoing Coronary Artery Bypass Grafting.Therapeutics and clinical risk management. 2023, 19: 447-454
Ping-Chen Hou, Nathalie Del Agua, Su M Lwin, Chao-Kai Hsu, John A McGrath. Innovations in the Treatment of Dystrophic Epidermolysis Bullosa (DEB): Current Landscape and Prospects.Therapeutics and clinical risk management. 2023, 19: 455-473
Bo Cong, Tao Sun, Yuchi Zhao, Mingqi Chen. Current and Novel Therapeutics for Articular Cartilage Repair and Regeneration.Therapeutics and clinical risk management. 2023, 19: 485-502
Hanqing Liu, Man Lu, Jiawei Hu, Guangzhao Fu, Qinyu Feng, Shengrong Sun, Chuang Chen. Medications and Food Interfering with the Bioavailability of Levothyroxine: A Systematic Review.Therapeutics and clinical risk management. 2023, 19: 503-523
Dahniel Sastow, Douglas Tremblay. Emerging Treatment Options for Myelofibrosis: Focus on Anemia.Therapeutics and clinical risk management. 2023, 19: 535-547
Na Zhao, Bowen Sun, Yuan Cheng, Jianliu Wang. Heterogeneity of CD40 Expression in Different Types of High-Risk Endometrial Cancer Affects Discordant Prognostic Outcomes.Therapeutics and clinical risk management. 2023, 19: 549-556
Hui Xu, Shuhui Hou, Zhengyi Ruan, Jianhua Liu. Comparing Anatomical and Functional Outcomes of Two Neovaginoplasty Techniques for Mayer-Rokitansky-Küster-Hauser Syndrome: A Ten-Year Retrospective Study with Swine Small Intestinal Submucosa and Homologous Skin Grafts.Therapeutics and clinical risk management. 2023, 19: 557-565
Patricia López-Chicón, Maria Luisa Pérez, Cristina Castells-Sala, Ana Rita Piteira, Oscar Fariñas, Jaime Tabera, Anna Vilarrodona. Quality by Design: Development of Safe and Efficacious Full-Thickness Acellular Dermal Matrix Based on EuroGTPII Methodologies.Therapeutics and clinical risk management. 2023, 19: 567-578